🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Another up day for oil helps Wall Street extend its rally

Published 03/09/2016, 03:12 PM
© Reuters. Traders work on the floor of the New York Stock Exchange shortly after the opening bell in New York
US500
-
DJI
-
CVX
-
AMGN
-
CELG
-
LCO
-
CMG
-
IXIC
-
NBI
-
REGN
-
SPNY
-

By Noel Randewich

(Reuters) - Wall Street built on a nearly month-old rally on Wednesday as a strong recovery in oil prices sent energy shares sharply higher.

Volatility in oil and stock prices has been linked for much of 2016 to a degree that has surprised many investors. Wednesday's market action extended that trend, with Brent crude rising above $40 a barrel, continuing its recovery from decade lows that led to stock market turmoil in January.

"It's still this puzzling correlation between the price of oil and stocks. It really is not supposed to play out this way," said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa.

"But given that oil drove the U.S. stock market down, it makes sense that stocks' rise would be tied to oil's comeback."

Since Feb. 11, the S&P 500 has gained 8.7 percent, repairing some of the damage caused by the S&P 500's worst January since 2009. The index remains down 3 percent for 2016.

At 2:42 p.m., the Dow Jones industrial average (DJI) was up 0.16 percent to 16,991.02 points and the S&P 500 (SPX) had gained 0.41 percent to 1,987.35.

The Nasdaq Composite (IXIC) added 0.43 percent to 4,668.78.

Seven of the 10 major S&P sectors were higher, led by a 1.64 percent rise in the energy sectors (SPNY). Chevron (N:CVX) jumped 4.73 percent and gave the biggest boost to the sector.

Investors were also looking to the European Central Bank, which will make a decision on its monetary policy on Thursday and is expected to increase its stimulus program.

While the U.S. Federal Reserve is not expected to raise interest rates at its meeting on March 15-16, the central bank has said it is on track to raise rates gradually this year.

Biotechs came under pressure after the U.S. government proposed a test program aimed at lowering Medicare drug costs. The Nasdaq Biotechnology sector (NBI) fell 1.27 percent.

Amgen's (O:AMGN) 2.98 percent decline was the biggest drag on the Nasdaq and the S&P 500. Regeneron (O:REGN) dropped 4.93 percent and Celgene (O:CELG) fell 1.77 percent.

Chipotle Mexican Grill (N:CMG) lost 3.78 percent. Already reeling from several food-borne illnesses, the company temporarily shut a Massachusetts restaurant after four employees fell sick.

Advancing issues outnumbered decliners on the NYSE by 2,117 to 843. On the Nasdaq, 1,693 issues rose and 1,049 fell.

© Reuters. Traders work on the floor of the New York Stock Exchange shortly after the opening bell in New York

The S&P 500 index showed 27 new 52-week highs and one new low, while the Nasdaq recorded 43 new highs and 36 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.